Unlike carb-heavy recovery drinks that can sit heavy or cause GI distress after a big workout, glutamine supports the recovery process without wrecking your stomach or leaving you bloated
The 2023 phase 2 double-blind, randomized controlled trial evaluating a GLP-1/GIP/glucagon receptor triagonist (retatrutide) in patients with the disease of obesity reported 24.2% weight loss at 48 weeks with 12 mg retatrutide
Potential cost: $0 if you qualify Potential savings: Full cost of medication If you're uninsured or underinsured and meet income requirements, you might get your medication completely free
#glutathione #NMN #collagen These Ultra X strips from @estherformula_global are 90% pure liposomal glutathionedesigned to absorb 264x faster than standard tablets
SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes